Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
Top Cited Papers
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 38 (1) , 41-57
- https://doi.org/10.2165/00003088-200038010-00003
Abstract
Drug interactions occur when the efficacy or toxicity of a medication is changed by administration of another substance. Pharmacokinetic interactions often occur as a result of a change in drug...Keywords
This publication has 162 references indexed in Scilit:
- Protease Inhibitors in Patients with HIV DiseaseClinical Pharmacokinetics, 1997
- Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue diseaseArthritis & Rheumatism, 1996
- Grapefruit Juice Alters the Systemic Bioavailability and Cardiac Repolarization of Terfenadine in Poor Metabolizers of TerfenadineThe Journal of Clinical Pharmacology, 1996
- Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variabilityAmerican Heart Journal, 1996
- Itraconazole interacts with felodipineJournal of the American Academy of Dermatology, 1995
- Itraconazole Affects Single‐Dose Terfenadine Pharmacokinetics and Cardiac Repolarization PharmacodynamicsThe Journal of Clinical Pharmacology, 1993
- Drug metabolism in end-stage liver diseaseJournal of Hepatology, 1990
- Pharmacokinetics and Blood Pressure Effects of Felodipine in Elderly Hypertensive PatientsClinical Pharmacokinetics, 1988
- Verapamil-Induced Carbamazepine NeurotoxicityEuropean Neurology, 1988
- Low Biological Availability of Ergotamine Tartrate After Oral Dosing in Cluster HeadacheCephalalgia, 1981